These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 31593028)

  • 1. Prognostic Significance of P16 Expression and P53 Expression in Primary Vaginal Cancer.
    Nwachukwu CR; Harris JP; Chin A; Von Eyben R; Giaretta S; Shaffer JL; Hiniker SM; Kapp DS; Folkins AK; Kidd EA
    Int J Gynecol Pathol; 2019 Nov; 38(6):588-596. PubMed ID: 31593028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of HPV, p16, and p53 protein expression in vaginal cancer: A systematic review.
    Rasmussen CL; Bertoli HK; Sand FL; Kjaer AK; Thomsen LT; Kjaer SK
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2144-2156. PubMed ID: 34546565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression and prognostic value of COX- 2, p16(INK4A) and p53 in patients with classical Hodgkin lymphoma].
    Shi Y; Gao Z; Liu C; Huang X; Song Y; Ping L; Zhou L; Zhao M; Huang X; Lai Y; Du T; Li M
    Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):926-32. PubMed ID: 26632465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
    Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
    Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area.
    Al-Swiahb JN; Huang CC; Fang FM; Chuang HC; Huang HY; Luo SD; Chen CH; Chen CM; Chien CY
    Arch Otolaryngol Head Neck Surg; 2010 May; 136(5):502-8. PubMed ID: 20479383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of senescence tumour markers and its implications on survival outcomes of breast cancer patients.
    Pare R; Soon PS; Shah A; Lee CS
    PLoS One; 2019; 14(4):e0214604. PubMed ID: 30998679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p16 and p53 in non-small-cell lung cancer: clinicopathological correlation and potential prognostic impact.
    Zhou Y; Höti N; Ao M; Zhang Z; Zhu H; Li L; Askin F; Gabrielson E; Zhang H; Li QK
    Biomark Med; 2019 Jun; 13(9):761-771. PubMed ID: 31157548
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved survival in p16-positive vaginal cancers across all tumor stages but no correlation with MIB-1.
    Feldbaum VM; Flowers LC; Oprea-Ilies GM
    Am J Clin Pathol; 2014 Nov; 142(5):664-9. PubMed ID: 25319982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer.
    Tzai TS; Tsai YS; Chow NH
    Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 and p53 can Serve as Prognostic Markers for Head and Neck Squamous Cell Carcinoma.
    Wang Y; Wang F; Wang S; Zhang L; Fu H; Sun L; Wang W; Liu C; Ren W; Gao L; Xing G; Ma X
    Int Dent J; 2024 Jun; 74(3):543-552. PubMed ID: 38105167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Significance of p53 and p16(ink4a) Status in a Contemporary North American Penile Carcinoma Cohort.
    Zargar-Shoshtari K; Spiess PE; Berglund AE; Sharma P; Powsang JM; Giuliano A; Magliocco AM; Dhillon J
    Clin Genitourin Cancer; 2016 Aug; 14(4):346-51. PubMed ID: 26794389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p14 expression differences in ovarian benign, borderline and malignant epithelial tumors.
    Cabral VD; Cerski MR; Sa Brito IT; Kliemann LM
    J Ovarian Res; 2016 Oct; 9(1):69. PubMed ID: 27770808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas.
    Shinohara S; Kikuchi M; Tona R; Kanazawa Y; Kishimoto I; Harada H; Imai Y; Usami Y
    Jpn J Clin Oncol; 2014 Mar; 44(3):232-40. PubMed ID: 24470584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1.
    Olsson H; Hultman P; Rosell J; Söderkvist P; Jahnson S
    BMC Urol; 2013 Jan; 13():5. PubMed ID: 23356517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina.
    Alonso I; Felix A; Torné A; Fusté V; del Pino M; Castillo P; Balasch J; Pahisa J; Rios J; Ordi J
    Gynecol Oncol; 2012 Apr; 125(1):194-9. PubMed ID: 22226684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters : A single-center analysis.
    Yildirim M; Müller von der Grün J; Winkelmann R; Fokas E; Rödel F; Ackermann H; Rödel C; Balermpas P
    Strahlenther Onkol; 2017 Apr; 193(4):305-314. PubMed ID: 28144684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer.
    Cheng YL; Lee SC; Harn HJ; Chen CJ; Chang YC; Chen JC; Yu CP
    Eur J Cardiothorac Surg; 2003 Feb; 23(2):221-8. PubMed ID: 12559346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study.
    Bian C; Li Z; Xu Y; Wang J; Xu L; Shen H
    World J Surg Oncol; 2015 Mar; 13():128. PubMed ID: 25890228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of p16 expression, nodal status, and smoking on oncologic outcomes of patients with head and neck unknown primary squamous cell carcinoma.
    Dixon PR; Au M; Hosni A; Perez-Ordonez B; Weinreb I; Xu W; Song Y; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    Head Neck; 2016 Sep; 38(9):1347-53. PubMed ID: 27002481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.